132 related articles for article (PubMed ID: 18299477)
21. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease.
Dvoráková S; Dvoráková K; Malíková M; Skába R; Vlcek P; Bendlová B
J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157
[TBL] [Abstract][Full Text] [Related]
22. Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Romei C; Tacito A; Molinaro E; Agate L; Bottici V; Viola D; Matrone A; Biagini A; Casella F; Ciampi R; Materazzi G; Miccoli P; Torregrossa L; Ugolini C; Basolo F; Vitti P; Elisei R
Clin Endocrinol (Oxf); 2015 Jun; 82(6):892-9. PubMed ID: 25440022
[TBL] [Abstract][Full Text] [Related]
23. Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism.
Rotondi M; Ercolino T; Fonte R; Lagonigro MS; Leporati P; Villani L; La Manna L; Mannelli M; Chiovato L
J Endocrinol Invest; 2009 Feb; 32(2):115-8. PubMed ID: 19411807
[TBL] [Abstract][Full Text] [Related]
24. [Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up].
Yao B; Liu X; Chen X; Dong TT; Liang H; Weng JP
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):914-8. PubMed ID: 18261274
[TBL] [Abstract][Full Text] [Related]
25. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
Menon MM; Simha MR
Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
[TBL] [Abstract][Full Text] [Related]
26. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
[TBL] [Abstract][Full Text] [Related]
27. RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotype.
Pinna G; Orgiana G; Riola A; Ghiani M; Lai ML; Carcassi C; Mariotti S
Thyroid; 2007 Feb; 17(2):101-4. PubMed ID: 17316110
[TBL] [Abstract][Full Text] [Related]
28. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
29. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A.
Chung YJ; Kim HH; Kim HJ; Min YK; Lee MS; Lee MK; Kim KW; Ki CS; Kim JW; Chung JH
Thyroid; 2004 Oct; 14(10):813-8. PubMed ID: 15588376
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
31. Coincidence of multiple endocrine neoplasia type 2A with acromegaly.
Saito T; Miura D; Taguchi M; Takeshita A; Miyakawa M; Takeuchi Y
Am J Med Sci; 2010 Oct; 340(4):329-31. PubMed ID: 20739875
[TBL] [Abstract][Full Text] [Related]
32. The relationship of cytomorphology of medullary thyroid carcinomas between family members with the same RET proto-oncogene mutation.
Chang JS; Chang CF; Yang WS; Chang TC
Acta Cytol; 2011; 55(6):556-62. PubMed ID: 22156466
[TBL] [Abstract][Full Text] [Related]
33. Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
Frank-Raue K; Rondot S; Schulze E; Raue F
Clin Lab; 2007; 53(5-6):273-82. PubMed ID: 17605401
[TBL] [Abstract][Full Text] [Related]
34. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
35. Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes.
Romei C; Mariotti S; Fugazzola L; Taccaliti A; Pacini F; Opocher G; Mian C; Castellano M; degli Uberti E; Ceccherini I; Cremonini N; Seregni E; Orlandi F; Ferolla P; Puxeddu E; Giorgino F; Colao A; Loli P; Bondi F; Cosci B; Bottici V; Cappai A; Pinna G; Persani L; Verga U; Boscaro M; Castagna MG; Cappelli C; Zatelli MC; Faggiano A; Francia G; Brandi ML; Falchetti A; Pinchera A; Elisei R;
Eur J Endocrinol; 2010 Aug; 163(2):301-8. PubMed ID: 20516206
[TBL] [Abstract][Full Text] [Related]
36. The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A.
Grey W; Hulse R; Yakovleva A; Genkova D; Whitelaw B; Solomon E; Diaz-Cano SJ; Izatt L
Endocr Pathol; 2017 Mar; 28(1):41-48. PubMed ID: 27704398
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic correlation between RET proto-oncogene mutation, imaging techniques, biochemical markers and morphological examination in MEN2A syndrome: case report and literature review.
Sovrea AS; Dronca E; Galatâr M; Radian S; Vornicescu C; Georgescu C
Rom J Morphol Embryol; 2014; 55(2):389-400. PubMed ID: 24969991
[TBL] [Abstract][Full Text] [Related]
38. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
39. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
Peppa M; Boutati E; Kamakari S; Pikounis V; Peros G; Panayiotides IG; Economopoulos T; Raptis SA; Hadjidakis D
Eur J Endocrinol; 2008 Dec; 159(6):767-71. PubMed ID: 18805915
[TBL] [Abstract][Full Text] [Related]
40. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
